Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

4-1BB: A promising target for cancer immunotherapy
Alyssa Min Jung Kim, Macy Rose Nemeth, Seung‐Oe Lim
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Therapeutic developments in pancreatic cancer
Zilun Hu, Eileen M. O’Reilly
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 7-24
Closed Access | Times Cited: 135
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
Janet M. Sasso, Rumiana Tenchov, Robert E. Bird, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 1951-2000
Open Access | Times Cited: 55
Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure
Tamás G. Gergely, Zsófia D. Drobni, Marinos Kallikourdis, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 443-462
Closed Access | Times Cited: 16
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Tianye Li, Mengke Niu, Jianwei Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing
Adèle Mangelinck, Agathe Dubuisson, Étienne Becht, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
Hui Yuwen, Huajing Wang, Tengteng Li, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1680-1698
Open Access | Times Cited: 6
The noncanonical NFκB pathway: Regulatory mechanisms in health and disease
Benancio N. Rodriguez, Helen J. Huang, Dennis J. Chia, et al.
WIREs Mechanisms of Disease (2024) Vol. 16, Iss. 6
Open Access | Times Cited: 5
Tumor necrosis factor superfamily signaling: life and death in cancer
Obada Ababneh, Daisuke Nishizaki, Shumei Kato, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1137-1163
Open Access | Times Cited: 5
The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy
Lidy Vannessa Mejía-Guarnizo, Paula Stefany Monroy-Camacho, Andrés David Turizo-Smith, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Influence of Microbiota on Tumor Immunotherapy
Xin Yu, Wenge Li, Zhi Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2264-2294
Open Access | Times Cited: 4
A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling
Chuling Zhuang, Shen Yang, Carlos G Gonzalez, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107393-107393
Open Access | Times Cited: 4
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
Ahmed E.I. Hamouda, Jessica Filtjens, Elisabeth Brabants, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Enhanced Natural Killer Cell Proliferation by Stress‐Induced Feeder Cells
Dong-Hyun Lee, Myeongkwan Song, Soonjo Kwon
Biotechnology and Bioengineering (2025)
Closed Access
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety
Tzu‐Yi Liao, Yen-Ling Liu, Chiao-Yun Chen, et al.
International Journal of Biological Macromolecules (2025), pp. 141003-141003
Closed Access
Targeting 4-1BB with Fucoidan from Fucus vesiculosus: A Strategy to Activate Macrophages and Remodel the Immunosuppressive Microenvironment for Pancreatic Cancer Therapy
Yi Wang, Yi Ding, Xiaomei Wei, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100721-100721
Open Access
4-1BB Antibodies in Oncology Clinical Trials: A Review
Robin Schwartz, Keerti P. Vajrala, Gerald S. Falchook
Journal of Immunotherapy and Precision Oncology (2025) Vol. 8, Iss. 2, pp. 121-131
Open Access
A mechanistic quantitative systems pharmacology model platform for translational efficacy evaluation and checkpoint combination design of bispecific immuno-modulatory antibodies
Yiyang Xu, Siyuan Yang, Qi Rao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity
Po-Lin Huang, Hung-Tsai Kan, Ching-Hsuan Hsu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
Albert Jang, Jake Lichterman, Jeffrey Y. Zhong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
What is the optimal duration, dose and frequency for anti-PD1 therapy of non-small cell lung cancer?
Chii Yang Kuah, Robert Monfries, Matteo Quartagno, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 5
Killer instincts: natural killer cells as multifactorial cancer immunotherapy
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Barking Up the Right Tree: Immune Checkpoint Signatures of Human and Dog Cancers
Mikołaj Kocikowski, Marcos Yébenes Mayordomo, Javier A. Alfaro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Enhancing the activation of T cells through anti‐CD3/CD28 magnetic beads by adjusting the antibody ratio
Y. H. Chen, Rui Zhao, Qi Fan, et al.
IUBMB Life (2024) Vol. 76, Iss. 12, pp. 1175-1185
Closed Access | Times Cited: 1
Uncovering the Expression Pattern of the Costimulatory Receptors ICOS, 4-1BB, and OX-40 in Exhausted Peripheral and Tumor-Infiltrating Natural Killer Cells from Patients with Cervical Cancer
José Manuel Rojas‐Díaz, Fabiola Solorzano‐Ibarra, Nadia Tatiana Garcia-Barrientos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8775-8775
Open Access | Times Cited: 1
Small molecules from antibody pharmacophores (SMAbPs) as a hit identification workflow for immune checkpoints
Somaya A. Abdel‐Rahman, Moustafa T. Gabr
Science Advances (2024) Vol. 10, Iss. 42
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top